# MGI Tech

MGI Tech has developed robust, high-throughput automated liquid handlers specifically optimized to feed its massive fleets of domestic gene sequencers.

Source: https://en.bioecon.ru/companies/mgi-tech/
Updated: 2026-06-24

- Country: China
- Ticker: SSE:688114

## Verifiable facts

| Fact | Value | Source |
| --- | --- | --- |
| Funding | $200+ million Series A in 2019; $1 billion Series B in 2020 | https://medbot.cn/companies/mgi-tech/, https://www.atlantis-press.com/article/126025249.pdf |
| Founded | 2016 | https://en.genomics.cn/en-history.html, https://medbot.cn/companies/mgi-tech/ |
| Headquarters | Shenzhen, China | https://medbot.cn/companies/mgi-tech/, https://novapharmanews.com/us/supplier-hub/mgi-tech-co-ltd, https://www.9fzt.com/detail/sh_688114_2_2799290323290.html |
| Production site | 7 production bases worldwide, including sites in Qingdao, Latvia, and the United States | https://mgi-tech.eu/, https://novapharmanews.com/us/supplier-hub/mgi-tech-co-ltd, https://www.9fzt.com/detail/sh_688114_2_2799290323290.html |
| Capacity | 2,000 liters of biological enzymes annually at Qingdao base [medium confidence] | https://subsites.chinadaily.com.cn/shandong/qingdao/xihaian/2025-02/11/c_1069682.htm |
| Certification | ISO 13485, ISO 14001, and ISO 27001 | https://medbot.cn/companies/mgi-tech/, https://mgi-tech.eu/, https://novapharmanews.com/us/supplier-hub/mgi-tech-co-ltd |
| Regulatory approval | NMPA Class III medical device approval for ultrasound robotics and numerous DNBSEQ sequencing platform models; CE certification for select products | http://money.finance.sina.com.cn/corp/view/vCB_AllBulletinDetail.php?id=11081182&stockid=688114, https://medbot.cn/companies/mgi-tech/, https://www.vcbeathealth.com/article/32945 |
| Headcount | Approximately 2,600 employees globally as of 2024 | https://medbot.cn/companies/mgi-tech/, https://novapharmanews.com/us/supplier-hub/mgi-tech-co-ltd, https://www.genomeweb.com/sequencing/mgi-tech-2024-revenues-3-percent-while-overseas-business-declines |
| Revenue | RMB 3.01 billion ($414.0 million) in 2024 | https://www.genomeweb.com/sequencing/mgi-tech-2024-revenues-3-percent-while-overseas-business-declines |

Independent sources: 9fzt.com, atlantis-press.com, en.genomics.cn, genomeweb.com, medbot.cn, money.finance.sina.com.cn, novapharmanews.com, subsites.chinadaily.com.cn, vcbeathealth.com

## Technologies

- [Bioinformatics & multi-omics](https://en.bioecon.ru/technology/bioinformatics-multi-omics/)
- [Lab automation & liquid handling](https://en.bioecon.ru/technology/lab-automation-liquid-handling/)
- [Lab automation & wet-lab robotics](https://en.bioecon.ru/technology/lab-automation-wet-lab-robotics/)
- [Sovereign genome databases (plants, animals, microbes)](https://en.bioecon.ru/technology/sovereign-genome-databases/)